@BiologyMusings@hoheyn@cnag_eu @nanostringtech No scarcity of resources for NanoString now :)
Patient square (has assets worth ~ $8 billion are on board with NSTG’s mission and product roadmap!
A riddle for scientists: what is (1) better than publishing in Nature, (2) more evil than reviewer 2, (3) the postdocs have it, (4) the Nobel prize winners need it, and (5) if you publish it you perish?
Are you ready to move from data to biological insights?
Melissa Davis from @SAiGENCI & the team developed a #bioinformatics tool standR to enhance the statistical power of GeoMx DSP #dataanalysis 👉https://t.co/7tmQf7pyc6 #FridayRead
https://t.co/7tmQf7pyc6
On the 1st day of 12 Days of NanoString, the gift 🎁 you will receive is a webinar about GeoMx DSP! https://t.co/hodzMmoaMk
The first of our Spatial Biology webinars highlighted everything you wanted to know about spatial biology but were too afraid to ask!
#SpatialBiology
It’s sad to see PIs treating their graduate trainees as liabilities and putting a price tag on them. Paul never once acknowledged how they bring revenue and add value to the PI’s career.
#academia#Gradschool
@pauldauenhauer I won’t refute the numbers, but it irks me a little that you are not acknowledging the fact that these graduate students generate the data that goes into these grants. The more students the PI trains, the closer they get to tenure. It’s a symbiotic relationship.
New research: The Emerging Role of Poly (ADP-Ribose) Polymerase Inhibitors as Effective Therapeutic Agents in Renal Cell Carcinoma: Renal cell carcinoma (RCC) is the sixth most common cancer in the US. However, no significant changes in… https://t.co/gSINJKDo0O #oncology